In vivo imaging with the CD19 probe in a syngeneic model of B-ALL demonstrated high specificity with minimal background uptake, primarily limited to kidney retention, comparable to leading reporter gene strategies for imaging CAR T cells (51). The gene discussed is CD19; the disease is acute lymphoblastic leukemia.